AKT1 and systemic sclerosis: TGFβ signaling is increased in skin of SSc patients, and TGFβ has been demonstrated to induce AKT signaling in dermal fibroblasts to lower myofibroblasts' sensitivity for Fas-mediated apoptosis (34, 37, 38).